SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-17-002785
Filing Date
2017-04-21
Accepted
2017-04-21 15:36:46
Documents
9
Period of Report
2017-06-02
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A tto-20170602xdef14a.htm DEF 14A 931755
2 GRAPHIC tto20170602xdef14a001.jpg GRAPHIC 4574
3 GRAPHIC tto20170602xdef14a002.jpg GRAPHIC 4910
4 GRAPHIC tto20170602xdef14a003.jpg GRAPHIC 79425
5 GRAPHIC tto20170602xdef14a004.jpg GRAPHIC 68382
6 GRAPHIC tto20170602xdef14a005.jpg GRAPHIC 64190
7 GRAPHIC tto20170602xdef14a006.jpg GRAPHIC 116722
8 GRAPHIC tto20170602xdef14a007.jpg GRAPHIC 28615
9 GRAPHIC tto20170602xdef14a008.jpg GRAPHIC 10109
  Complete submission text file 0001558370-17-002785.txt   1453038
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36571 | Film No.: 17775480
SIC: 3841 Surgical & Medical Instruments & Apparatus